Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14967061 | 0.92 | TP53 (0.58) | TP53OPRM1FDPSCA2CA1 | |
| SCHEMBL10336760 | 0.84 | TP53 (0.41) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL776309 | 0.82 | TP53 (0.41) | TP53OPRM1TSHRSMN1; SMN2CYP3A4 | |
| SCHEMBL5637608 | 0.81 | TP53 (0.46) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL329736 | 0.81 | TP53 (0.46) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL11467459 | 0.80 | TP53 (0.52) | TP53OPRM1CYP3A4FDPSCA1 | |
| SCHEMBL6113317 | 0.79 | TP53 (0.45) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL222612 | 0.79 | TP53 (0.45) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL6113165 | 0.79 | TP53 (0.45) | TP53OPRM1DNM1SLC15A1TSHR | |
| SCHEMBL6113068 | 0.79 | TP53 (0.45) | TP53OPRM1DNM1SLC15A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110074-A1 | ELECTROCHEMICAL CELL COMPRISING A SULFUR CATHODE WITH CARBONACEOUS MATERIALS AND SPARINGLY SOLVATING ELECTROLYTES, METHOD OF PREPARATION AND USES THEREOF | FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) | 2024-05-30 | — | — | WO | claimed |
| US-11456485-B2 | Sulfone sulfonylimide combinations for advanced battery chemistries | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2022-09-27 | — | — | US | claimed |
| US-11024846-B2 | High energy/power density, long cycle life, safe lithium-ion battery capable of long-term deep discharge/storage near zero volt and method of making and using the same | ADA TECHNOLOGIES, INC. (US) | 2021-06-01 | — | — | US | claimed |
| US-20210066754-A1 | SULFONE SULFONYLIMIDE COMBINATIONS FOR ADVANCED BATTERY CHEMISTRIES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2021-03-04 | — | — | US | claimed |
| US-10355311-B2 | Fluoride ion battery electrolyte compositions | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2019-07-16 | — | — | US | claimed |
| US-9331360-B2 | Fluoride ion battery electrolyte compositions | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-05-03 | — | — | US | claimed |
| US-9166249-B2 | Fluoride ion battery compositions | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-10-20 | — | — | US | claimed |
| US-8916619-B2 | Method of producing porous polymer film and porous polymer film produced by the method | CANON KABUSHIKI KAISHA (JP) | 2014-12-23 | — | — | US | claimed |
| CN-103563154-A | Fluoride ion battery compositions | CONTOUR ENERGY SYSTEMS INC | 2014-02-05 | — | — | CN | claimed |
| CN-102812586-A | Fluoride ion battery electrolyte composition | CONTOUR ENERGY SYSTEMS INC | 2012-12-05 | — | — | CN | claimed |
| WO-2011072166-A1 | FLUORIDE ION BATTERY ELECTROLYTE COMPOSITIONS | Contour Energy Systems, Inc. (US) | 2011-06-16 | — | — | WO | claimed |
| US-20110143219-A1 | Fluoride Ion Battery Electrolyte Compositions | Contour Energy Systems, Inc. (US) | 2011-06-16 | — | — | US | claimed |
| WO-2010150794-A1 | METHOD OF PRODUCING POROUS POLYMER FILM AND POROUS POLYMER FILM PRODUCED BY THE METHOD | CANON KABUSHIKI KAISHA (JP) | 2010-12-29 | — | — | WO | claimed |
| EP-0138740-B1 | SYNTHETIC RESIN WOUND DRESSING AND METHOD OF MANUFACTURING | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1991-03-06 | — | — | EP | claimed |
| EP-0344090-A2 | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-11-29 | — | — | EP | claimed |
| US-4857334-A | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-08-15 | — | — | US | claimed |
| US-4747845-A | POLYACRYLATES OR POLYACRYLAMIDE WITH SOLVENT AND HYDROGEN BONDING PLASTICIZER | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1988-05-31 | — | — | US | claimed |
| US-4725271-A | POLYMER, SOLVENT, HYDROGEN BONDING PLASTICIZER; PREFORMED OR CURED IN SITU; TIMED RELEASE | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1988-02-16 | — | — | US | claimed |
| US-4563184-A | POLYHYDROXYETHYL METHACRYLATE, POLYOXYETHYLENE GLYCOL, PLASTICIZER | ENQUAY, INC. | 1986-01-07 | — | — | US | claimed |
| EP-0138740-A2 | Synthetic resin wound dressing and method of manufacturing | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1985-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210066754-A1 | SULFONE SULFONYLIMIDE COMBINATIONS FOR ADVANCED BATTERY CHEMISTRIES | HCN2, NCS1, HCN3 | TP53 852/4885OPRM1 4852/4885DNM1 2329/4885 |
| US-11456485-B2 | Sulfone sulfonylimide combinations for advanced battery chemistries | HCN2, NCS1, HCN3 | TP53 852/4885OPRM1 4852/4885DNM1 2329/4885 |
| US-10355311-B2 | Fluoride ion battery electrolyte compositions | SLC26A3, SLC9B2, SLC8A1 | TP53 1723/4885OPRM1 4531/4885DNM1 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.